Prelle et al. evaluated the incidence of secondary mutations in a cohort of 144 pediatric and adult patients with MLL-r leukemias, of which 100 individuals had t(4;11) mutations and the remaining 44 patients had a variety of other fusions. The gene discussed is KMT2A; the disease is leukemia.